Checking ASND unusual options activity helps you spot when traders are making outsized bets on Ascendis Pharma A/S before the broader market catches on. Ascendis Pharma A/S's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ASND unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ASND unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ASND unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ASND unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Catalysts rarely arrive without a footprint, and ASND unusual options activity is often where that footprint shows up first. Our scanner tracks Ascendis Pharma A/S's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ASND unusual options volume on the call side or chasing put sweeps, Ascendis Pharma A/S's unusual options flow today is one click away, so put it on your radar before the headlines hit.
